Search Results - "RUDZKI, Z"
-
1
Two Cases of γ-Heavy Chain Disease and a Review of the Literature
Published in Case reports in hematology (01-01-2018)“…Gamma heavy chain disease (γ-HCD) is a rare lymphoproliferative disorder characterised by the production of a truncated immunoglobulin heavy chain. Fewer than…”
Get full text
Journal Article -
2
-
3
Monitoring chronic myeloid leukaemia therapy by real‐time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics
Published in British journal of haematology (01-12-1999)“…We have developed a rapid real‐time quantitative PCR method for measuring BCR‐ABL mRNA levels in peripheral blood in chronic myeloid leukaemia (CML). The…”
Get full text
Journal Article -
4
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase
Published in Leukemia (01-12-2003)“…We analyzed molecular responses in 55 newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients enrolled in a phase 3 study (the IRIS trial)…”
Get full text
Journal Article -
5
A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family
Published in Haematologica (Roma) (01-05-2008)“…1 Experimental Hematology, Department of Biomedicine, Basel University Hospital, Basel, Switzerland 2 Department of Pathomorphology, Collegium Medicum,…”
Get full text
Journal Article -
6
A novel BCR–ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia‐positive chronic myeloid leukaemia
Published in British journal of haematology (01-06-2000)“…An atypical BCR–ABL transcript in a patient with Philadelphia (Ph)‐positive chronic myeloid leukaemia (CML) was detected using a long polymerase chain reaction…”
Get full text
Journal Article -
7
Why we will need to learn new skills to control cancer
Published in Internal medicine journal (01-03-2007)“…As a society and as specialists involved in the diagnosis and management of cancer, we must begin to find new cost‐effective ways to provide equitable access…”
Get full text
Journal Article -
8
Megakaryocytic features useful for the diagnosis of myeloproliferative disorders can be obtained by a novel unsupervised software analysis
Published in Histology and histopathology (01-08-2006)“…An unsupervised method for megakaryocyte detection and analysis is proposed, in order to validate supplementary tools which can be of help in supporting the…”
Get full text
Journal Article -
9
Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-11-2000)“…Anaphylaxis to factor IX (FIX) in patients with haemophilia B is a rare and life‐threatening complication that has been reported to occur in association with…”
Get full text
Journal Article -
10
Two Cases of [gamma]-Heavy Chain Disease and a Review of the Literature
Published in Case reports in hematology (01-01-2018)“…Gamma heavy chain disease ([gamma]-HCD) is a rare lymphoproliferative disorder characterised by the production of a truncated immunoglobulin heavy chain. Fewer…”
Get full text
Journal Article -
11
The relationship between gastric cancer cells circulating in the blood and microsatellite instability positive gastric carcinomas
Published in Alimentary pharmacology & therapeutics (01-04-2002)“…Background: Cancers characterized by microsatellite instability may be biologically different from their counterparts with stable microsatellite sequences…”
Get full text
Journal Article -
12
Preliminary report on pathology of colorectal cancer in Poland in 1995 and 1975 : is it still the same disease?
Published in International journal of colorectal disease (01-12-1999)“…Over past three decades in Poland we have seen a steady increase in the incidence of colorectal cancer. It is unclear whether this phenomenon is associated…”
Get full text
Journal Article -
13
A single, large deletion accounts for all the beta-globin gene mutations in twenty families from Sabah (North Borneo), Malaysia. Mutation in brief no. 240. Online
Published in Human mutation (1999)“…Beta-thalassemia major is one of the commonest genetic disorders in South-East Asia. The spectrum of beta-thalassemia mutations in the various ethnic…”
Get full text
Journal Article -
14
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
Published in Blood (01-07-2003)“…Imatinib-treated chronic myeloid leukemia (CML) patients with acquired resistance commonly have detectable BCR-ABL kinase domain mutations. It is unclear…”
Get full text
Journal Article -
15
Changes in CD44 Expression during Carcinogenesis of the Mouse Colon
Published in Experimental and molecular pathology (01-04-1997)“…CD44 glycoprotein is the main extracellular receptor for hyaluronic acid. The CD44 gene is composed of 20 exons and encodes a variety of isoforms generated by…”
Get full text
Journal Article -
16
High frequency of point mutations clustered within the adenosine triphosphate–binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance
Published in Blood (01-05-2002)“…Point mutations were found in the adenosine triphosphate (ATP) binding region of BCR/ABL in 12 of 18 patients with chronic myeloid leukemia (CML) or…”
Get full text
Journal Article -
17
Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia
Published in The New England journal of medicine (09-10-2003)“…Measurement of the transcripts of BCR-ABL, the key molecular abnormality in chronic myeloid leukemia (CML), provides an estimate of the burden of leukemic…”
Get full text
Journal Article -
18
-
19
-
20
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations
Published in Blood (01-11-2004)“…Mutations within the BCR-ABL kinase domain in imatinib-treated chronic myeloid leukemia (CML) are the main mechanism of acquired resistance. The early…”
Get full text
Journal Article